$0.670 (-5.63%)

Volume: 2.643M

Closed: Jan 27, 2023

Hollow Logo Score: 1.038
Akebia Therapeutics Stock
$0.670 (-5.63%)

Volume: 2.643M

Closed: Jan 27, 2023

Score Hollow Logo 1.038
NASDAQ:AKBA

Akebia Therapeutics Stock Price (Quote)

$0.670 ( -5.63% ) Friday, 27th Jan 2023

Range Low Price High Price Comment
30 days $0.409 $0.770 Friday, 27th Jan 2023 AKBA stock ended at $0.670. This is 5.63% less than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 28.21% from a day low at $0.560 to a day high of $0.718.
90 days $0.243 $0.770
52 weeks $0.241 $2.93

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
2023-01-27 $0.700 $0.718 $0.560 $0.670 2 642 750
2023-01-26 $0.730 $0.730 $0.701 $0.710 1 737 203
2023-01-25 $0.710 $0.730 $0.710 $0.712 1 074 694
2023-01-24 $0.710 $0.750 $0.701 $0.722 1 400 125
2023-01-23 $0.737 $0.737 $0.701 $0.710 915 213
2023-01-20 $0.700 $0.745 $0.690 $0.737 1 194 736
2023-01-19 $0.744 $0.744 $0.672 $0.709 1 434 731
2023-01-18 $0.728 $0.770 $0.710 $0.719 1 631 937
2023-01-17 $0.719 $0.740 $0.695 $0.730 944 447
2023-01-13 $0.681 $0.728 $0.680 $0.695 1 031 648
2023-01-12 $0.688 $0.690 $0.650 $0.690 836 400
2023-01-11 $0.650 $0.688 $0.632 $0.670 982 100
2023-01-10 $0.660 $0.660 $0.630 $0.647 690 303
2023-01-09 $0.640 $0.694 $0.633 $0.645 1 340 000
2023-01-06 $0.700 $0.710 $0.622 $0.642 2 133 500
2023-01-05 $0.639 $0.688 $0.626 $0.670 2 319 861
2023-01-04 $0.630 $0.650 $0.580 $0.633 3 399 855
2023-01-03 $0.585 $0.651 $0.550 $0.623 3 899 374
2022-12-30 $0.491 $0.578 $0.490 $0.577 3 566 240
2022-12-29 $0.423 $0.540 $0.423 $0.506 4 686 238
2022-12-28 $0.410 $0.440 $0.409 $0.423 1 216 768
2022-12-27 $0.420 $0.440 $0.412 $0.412 1 369 246
2022-12-23 $0.407 $0.440 $0.407 $0.427 681 203
2022-12-22 $0.406 $0.450 $0.404 $0.411 1 869 794
2022-12-21 $0.412 $0.434 $0.409 $0.411 862 801
2022-12-20 $0.399 $0.446 $0.384 $0.420 1 990 372
2022-12-19 $0.455 $0.460 $0.365 $0.400 2 717 908
2022-12-16 $0.440 $0.479 $0.430 $0.442 3 357 121
2022-12-15 $0.450 $0.460 $0.390 $0.454 2 442 383
2022-12-14 $0.428 $0.480 $0.392 $0.453 3 589 417
2022-12-13 $0.395 $0.440 $0.386 $0.424 3 789 975
2022-12-12 $0.308 $0.408 $0.308 $0.373 3 834 057
2022-12-09 $0.298 $0.318 $0.298 $0.310 689 721
2022-12-08 $0.309 $0.310 $0.293 $0.300 1 786 806
2022-12-07 $0.293 $0.308 $0.281 $0.300 2 899 800
2022-12-06 $0.290 $0.295 $0.281 $0.285 2 378 911
2022-12-05 $0.281 $0.300 $0.281 $0.292 2 185 177
2022-12-02 $0.297 $0.300 $0.279 $0.290 1 852 802
2022-12-01 $0.270 $0.295 $0.266 $0.292 1 297 111
2022-11-30 $0.250 $0.280 $0.250 $0.271 2 298 848
2022-11-29 $0.255 $0.259 $0.243 $0.250 996 311
2022-11-28 $0.260 $0.260 $0.250 $0.251 947 177
2022-11-25 $0.259 $0.265 $0.253 $0.256 773 178
2022-11-23 $0.260 $0.267 $0.253 $0.261 720 317
2022-11-22 $0.260 $0.270 $0.252 $0.260 1 341 211
2022-11-21 $0.258 $0.265 $0.250 $0.255 884 142
2022-11-18 $0.251 $0.264 $0.246 $0.254 985 453
2022-11-17 $0.257 $0.269 $0.243 $0.265 2 472 249
2022-11-16 $0.270 $0.270 $0.251 $0.254 883 641
2022-11-15 $0.262 $0.275 $0.252 $0.259 1 273 967

Hot Stocks To Watch:

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT